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BACKGROUND: The possible benefit of lifetime physical activity (PA) in reducing prostate cancer incidence and mortality is unclear.
METHODS: A prospective cohort of 45887 men aged 45–79 years was followed up from January 1998 to December 2007 for
prostate cancer incidence (n¼2735) and to December 2006 for its subtypes and for fatal (n¼190) prostate cancer.
RESULTS: We observed an inverse association between lifetime (average of age 30 and 50 years, and baseline age) total PA levels and
prostate cancer risk. Multivariate-adjusted incidence in the top quartile of lifetime total PA decreased by 16% (95% confidence
interval (CI)¼2–27%) compared with that in the bottom quartile. We also observed an inverse association between average
lifetime work or occupational activity and walking or bicycling duration and prostate cancer risk. Compared with men who mostly sit
during their main work or occupation, men who sit half of the time experienced a 20% lower risk (95% CI¼7–31%). The rate ratio
linearly decreased by 7% (95% CI¼1–12%) for total, 8% (95% CI¼0–16%) for localised and 12% (95% CI¼2–20%) for advanced
prostate cancer for every 30min per day increment of lifetime walking or bicycling in the range of 30 to 120min per day.
CONCLUSION: Our results suggest that not sitting for most of the time during work or occupational activity and walking or bicycling
more than 30min per day during adult life is associated with reduced incidence of prostate cancer.
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An expert panel from the World Cancer Research Fund/American
Institute for Cancer Research has reported that physical activity
(PA) may specifically reduce the risk of advanced or aggressive
prostate cancer, but no formal judgment was made regarding the
strength of the evidence (WCRF/AICR, 2007). A review of
24 studies of PA and prostate cancer risk found the evidence to
be inconsistent, mainly because of the heterogeneous nature of
neoplasm, and urged an investigation of PA at different ages as
a potentially productive approach (Friedenreich and Thune, 2001).
Two case–control studies have included a measure of lifetime
PA (Friedenreich et al, 2004; Wiklund et al, 2008); one found a
non-significant decrease in prostate cancer risk for lifetime
recreational activity (Friedenreich et al, 2004), whereas the
contrary was found in the other study (Wiklund et al, 2008). No
cohort study has examined detailed measures of lifetime PA in
relation to prostate cancer incidence or mortality.
To investigate lifetime total PA – and more specifically work or
occupational activity and walking or bicycling, the main component
of active living – in relation to incident and fatal prostate cancer,
we analysed data from a population-based cohort of middle-aged
and elderly men who reported their usual PA in the previous year,
at age 50 and 30 years.
MATERIALS AND METHODS
The population-based cohort of Swedish men was established in
1997–1998, when all eligible men (n¼100303) aged 45–79 years
residing in Va ¨stmanland and O ¨rebro counties (central Sweden)
received an invitation to participate in the study, along with a self-
administered questionnaire. This covered walking or bicycling;
current waist, hip and height measurements; education level;
cigarette smoking; alcohol consumption; diabetes; family history
of prostate cancer; and other lifestyle factors. A total of 48645 men
returned the questionnaire.
In this analysis, we excluded participants who returned an
incomplete questionnaire (n¼92), died before 1 January 1998
(n¼55), moved out of the study area (n¼19) or had a previous
cancer diagnosis (n¼2592); after exclusions, 45887 men were
included. This large population-based cohort is representative of
Swedish males aged 45–79 years, in terms of age distribution,
educational level and prevalence of overweight (Norman et al,
2002). Incidence rates are also comparable; for example, the
incidence rate among men aged 65–69 years is 603 in the cohort
and 595 per 100000 men in entire Sweden (NBHW, 2000).
Information on usual PA levels at different ages (current, age 50
years and age 30 years) was collected using five questions relating
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yto occupation, housework, walking or cycling, leisure-time exercise
and inactive leisure time (e.g., watching TV or reading). There
were six predefined activity levels for occupational activity (from
mostly sitting down to heavy manual labour) and five to six
predefined categories for time spent on different activities, such as
walking or bicycling (hardly ever to more than 90min per day),
home or household work (less than 1h to more than 8h per day),
inactive leisure time (from 2h per day or less to 5h per day or
more) and active leisure-time exercising (from less than 1h to
more than 5h per week). There was also an open question
regarding the number of sleeping hours per day.
Physical activity levels for specific activities were estimated by
multiplying reported duration (hours per day) by absolute
intensity. This was determined by the rate of work being
performed and does not take into account the physiological
capacity of the individual. The absolute intensity of activities,
defined in multiples of the metabolic equivalent (MET, kcal
kg
 1 h) of sitting quietly for 1h, was based on a compendium of
PAs (Ainsworth et al, 2000). More details regarding the calcula-
tions and assigned intensity values used can be found elsewhere
(Norman et al, 2001). The total PA scores at age 30 and 50 years,
and at baseline age, were calculated by summing the products of
duration and intensity for each PA type. The major contributor
(60%) to active leisure time was walking or bicycling.
The PA questions were validated using two 7-day activity
records that were maintained 6 months apart in a group of Swedish
men aged 44–78 years. The 7-day activity records were shown to
correlate well with the total PA questionnaire data, with a
Spearman correlation coefficient of 0.6. The reproducibility of
total PA, as reflected by the Spearman correlation coefficient
between the first questionnaire and that obtained 6 months later,
was 0.65 (Norman et al, 2001).
The adult lifetime average total PA (MET, h per day), work or
occupational activity level and walking or bicycling (min per day)
were estimated for each participant, with at least two observed
values as the average of the three measures of PA at ages 30 and 50
years, and at baseline age.
Incident cases of prostate cancer were ascertained by compu-
terised record linkage with the Swedish National Cancer Register
and the Regional Cancer Register covering the study area, both of
which are estimated to be almost 100% complete (Mattsson and
Wallgren, 1984). From 1 January 1998 through to 31 December
2007, during 416172 person-years, we documented 2735 newly
diagnosed cases. Information on tumour–node–metastasis stage,
the Gleason grade and the value of prostate-specific antigen (PSA)
at prostate cancer diagnosis were available from the Swedish
Prostate Cancer Quality Registry. Incident cases were classified by
subtype as localised (T1–2, NX-0, MX-0 or PSAo20 or Gleason
gradep7) and advanced (4T2, NX-1, MX-1 or PSA4100 or
Gleason grade47). From 1 January 1998 through to 31 December
2006, during 377904 person-years, we documented 1098 localised
and 970 advanced cancers at diagnosis, 190 of which were fatal.
Information on prostate cancer death was ascertained through
linkage to the Swedish Register of Death Causes at the National
Board of Health and Welfare. Classification of deaths was based on
International Classification of Diseases (ICD-10, code 61 for
prostate cancer).
Statistical analysis
The Cox proportional hazards model was used to estimate prostate
cancer rate ratios (RRs) and 95% confidence intervals associated
with lifetime average PA (total daily score, work or occupational
and walking or bicycling) levels.
For incidence analyses, each participant accrued follow-up time
from 1 January 1998 until the date of prostate cancer diagnosis,
death from any cause or study end (31 December 2007 for total
prostate cancer or 31 December 2006 for subtypes of prostate
cancer), whichever came first. For fatal prostate cancer analysis,
each participant accrued follow-up time from 1 January 1998 until
the date of prostate cancer death, death from any cause or study
end (31 December 2006), whichever came first.
In all multivariate analyses, we adjusted for baseline age, waist-
to-hip ratio, height, diabetes, alcohol consumption, smoking
status, years of education, total energy intake, consumption of
dairy product and red meat and parental history with respect to
prostate cancer.
We checked whether the proportional hazard assumption was
reasonable in the multivariate models. Scaled Schoenfeld’s resi-
duals were regressed against survival time. There was no evidence
of departure from the assumption. Restricted cubic splines (three
knot positions corresponding to quartiles of observations) were
used to flexibly model and graph the multivariate-adjusted rate
ratio for lifetime average total daily PA and walking or bicycling
duration in predicting prostate cancer incidence and mortality. We
examined potential effect modification for the relationship
between lifetime total PA and total cancer incidence according to
the interval between study entry and diagnosis, baseline age (p60,
460 years), educational level (post-secondary education vs lower)
and waist–hip ratio (o0.95, X0.95), and tested the statistical
significance of the interactions using the Wald test.
Of the participants, 60% had complete data on lifetime PA
activity (age 30 and 50 years, and current age), 20% had one
missing value (one of three time periods not reported), 10% had
two missing values and only 10% had all three missing values. The
proportion of incomplete data was 21% for waist–hip ratio and
less than 5% for the remaining covariate data. A complete-subjects
approach reduced the analytic cohort to 28515 men, in which there
were 1709 incidences of prostate cancer and 100 fatal prostate
cancer cases. To evaluate a potential effect of missing values on the
observed results, we used multivariate imputation by chained
equations to obtain five imputed data sets of the analytic cohort
including 45887 men (van Buuren et al, 1999; Royston, 2004). The
rate ratios estimated on imputed data sets were pooled together
using Rubin’s rule to obtain valid statistical inferences (Rubin and
Schenker, 1986). We compared the rate ratios based on the two
approaches (complete-subjects and multiple imputation) by
calculating the relative difference defined as (RR complete
case RR multiple imputation)/RR multiple imputation.
All reported P-values are two-sided. All statistical analyses were
performed with Stata, version 10 (StataCorp, College Station, TX, USA).
RESULTS
Baseline characteristics of the study population by quartiles of
lifetime total PA are shown in Table 1. Compared with men in the
bottom quartile of total activity, those in the higher quartiles were
more likely to avoid sitting most of the time during their main
work or occupation, more likely to walk or bike more than 60min
per day and less likely to have post-secondary education. Prostate
cancer cases had an average age of 66 years at baseline and 72 years
at diagnosis. The majority of cases (80%) were diagnosed because
of clinical symptoms followed by health checkups (20%). Age and
multivariate-adjusted rate ratios for prostate cancer incidence
(total, localised and advanced) and mortality according to quartiles
of lifetime average total PA are shown in Table 2.
Lifetime total PA was significantly inversely associated with
rates of total prostate cancer incidence. The age-adjusted rate ratio
for the top quartile of lifetime total PA was associated with 17%
lower risk of total prostate cancer compared with the bottom
quartile. Further adjustment for waist–hip ratio, height, history of
diabetes, alcohol consumption, smoking status, educational level,
total energy intake, consumption of dairy product and meat and
parental history of prostate cancer did not substantially change the
estimate; incidence in the top quartile of lifetime total PA
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The inverse relationship between lifetime total PA modelled as a
continuous variable and total prostate cancer risk is presented
graphically in Figure 1. Excluding the first 4 years of follow-up did
not change this association with PA; the multivariate-adjusted rate
ratio in the top quartile of total PA significantly decreased by 17%
(95% CI¼1–30%) compared with the bottom.
The magnitude and direction of the estimates based on
complete subjects and multiple imputation were overall similar.
The multivariate-adjusted rate ratio based on five imputed data
sets in the top quartile of total PA significantly decreased by 14%
(95% CI¼2–25%) compared with the bottom. The averages of the
relative differences were 0.7% for the incidence of total prostate
cancer, 0.2% for localised, 1.1% for advanced and 13.5% for fatal.
In addition, we examined whether the influence of lifetime total PA
on incidence differed according to the interval between study entry
and diagnosis; no significant effect modification was observed
(Pinteraction¼0.30). Furthermore, there was no evidence of a
Table 1 Age-standardized baseline characteristics by quartiles of lifetime (age 30 and 50 years, and current age) average total physical activity in the
cohort of 45887 Swedish men aged 45–79 years followed-up from 1998 to 2007
Quartiles of total physical activity, range (median), MET-h per day
a
Characteristics
b
Q1,
o39 (37)
Q2,
39–42.4 (41)
Q3,
42.5–46 (44)
Q4,
446 (48) Missing
No. of individuals 9143 9143 9143 9143 9315
Not mostly sitting at work or occupation (%) 48 97 99 100 91
Walking or bicycling 460min per day (%) 3 11 20 40 23
Age (mean, years) 57 60 60 61 64
Body mass index (kgm
 2)2 6 2 6 2 6 2 6 2 6
Height (cm) 178 178 177 177 176
Waist–hip ratio X0.95 (%) 42 40 41 40 45
Prostate diagnosis by symptoms (%) 71 76 79 68 82
History of diabetes (%) 8 8 8 8 13
Family history of prostate cancer (%) 6 7 7 9 11
Alcohol consumption (never, %) 4 4 5 6 7
Smoking (never, %) 39 38 35 35 33
Education (412 years, %) 32 21 11 5 11
Intake (mean)
Calories per day 2609 2670 2746 2923 2611
Dairy product (times per day)
c 5.3 5.4 5.7 6.2 5.4
Red meat (times per day)
d 1.3 1.3 1.3 1.3 1.2
aAll factors, except age, were directly standardized to the age distribution of the study participants.
bLifetime total physical activity (home or household work, work or occupation,
walking or bicycling, exercise, and watching TV or reading) is the average of daily activities at age 30 and 50 years, and current (baseline) age, and it is expressed in metabolic
equivalents (METs).
cDairy products indicates milk, cheese, yogurt, cream, and cre `me fraiche.
dRed meat indicates meatballs, pork, veal, sausage, and black pudding.
Table 2 Age-adjusted and multivariate rate ratios for total, localised, advanced and fatal prostate cancer according to quartiles of lifetime (age 30 and 50
years, and current age) average total physical activity levels
Lifetime average total physical activity, MET-hours/day
Q1,
o39 (37)
Q2,
39–42.4 (41)
Q3,
42.5–46 (44)
Q4,
446 (48) P-trend
Total-incidence prostate cancer
No. of cases 419 414 447 429
Age-adjusted RR (95% CI) 1 0.86 (0.75–0.98) 0.91 (0.79–1.04) 0.83 (0.73–0.96) 0.030
Multivariate RR (95% CI)
a 1 0.86 (0.75–0.99) 0.91 (0.79–1.05) 0.84 (0.73–0.98) 0.065
Localised
No. of cases 188 162 156 182
Age-adjusted RR (95% CI) 1 0.74 (0.60–0.91) 0.70 (0.56–0.86) 0.78 (0.64–0.96) 0.045
Multivariate RR (95% CI)
a 1 0.75 (0.61–0.93) 0.73 (0.58–0.91) 0.82 (0.66–1.03) 0.184
Advanced
No. of cases 133 155 172 126
Age-adjusted RR (95% CI) 1 0.97 (0.77–1.23) 1.05 (0.84–1.32) 0.73 (0.57–0.94) 0.014
Multivariate RR (95% CI)
a 1 0.98 (0.78–1.25) 1.07 (0.84–1.36) 0.75 (0.58–0.98) 0.035
Fatal prostate cancer
No. of cases 20 25 27 28
Age-adjusted RR (95% CI) 1 0.97 (0.54–1.75) 1.02 (0.57–1.82) 0.99 (0.56–1.78) 0.989
Multivariate RR (95% CI)
a 1 0.96 (0.53–1.75) 1.02 (0.55–1.87) 0.98 (0.53–1.83) 0.999
Abbreviations: CI, confidence interval; RR, rate ratio.
aMultivariate RRs were adjusted for age (years, continuous), waist–hip ratio (quartiles), height (continuous), diabetes (yes or
no), alcohol consumption (current drinker, former drinker and never drinker), smoking status (current smoker, former smoker and never smoked), years of education (1–9 years,
9–12 years, more than 12 years), total energy intake (calories, continuous), consumption of dairy product (times per day, continuous) and red meat (times per day, continuous)
and parental history with respect to prostate cancer (yes, no or not known). A complete-subjects analysis automatically discarded missing values on any covariate.
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(Pinteraction¼0.61), educational level (Pinteraction¼0.28) or waist–
hip ratio (Pinteraction¼0.80).
For subtypes (Table 2), the multivariate-adjusted rate ratio in the
top quartile of lifetime total PA was 18% lower (95% CI¼0.66–1.03)
for localised and 25% lower (95% CI¼0.58–0.98) for advanced
prostate cancer compared with the bottom quartile.
We then investigated the mutually adjusted effect of lifetime
work or occupational activity and leisure-time walking or bicycling
– the main determinants of the total PA score – on prostate cancer
risk. Compared with men who mostly sit during their main work
or occupation and controlling for walking or bicycling levels, men
who sit half of the time experienced a 20% lower risk (95% CI¼
7–31%) of prostate cancer (Table 3). Heavy manual occupations
were associated with a significantly lower risk of 28% (95%
CI¼10–43%) compared with sedentary work or occupation. The
multivariate-adjusted (including work or occupation activity)
incidence for those men walking or bicycling a lifetime average
duration of over 60min per day was 14% (95% CI¼2–24%) lower
than in those who walked or biked 20–40min per day (Table 4).
Advanced prostate cancer incidence decreased by 26% (95%
CI¼8–41%) for men walking or bicycling more than 60min per
day compared with those who walked or biked 20–40min per day.
Examining the associations with lifetime average walking or
bicycling duration as a continuous variable, and using a reference
value of 30min per day, the adjusted rate ratio for total prostate
cancer decreased linearly by 7% (95% CI¼1–12%) for every
30min per day increment in the range of 30–120min per day. No
significant trend was observed in the incidence of total prostate
cancer below a lifetime average walking or bicycling of 30min per
day (Figure 2A).
Compared with men who walked or biked a lifetime average of
30min per day, the adjusted rate ratio for localised prostate cancer
linearly decreased by a marginally significant 8% (95% CI¼
0–16%) for every 30min per day increment of lifetime average
walking or bicycling in the range of 30–120min per day. The
adjusted rate ratio for advanced disease linearly decreased by 12%
(95% CI¼2–20%) for every 30min per day increment in the range
of 30–120min per day (Figure 2B). For fatal prostate cancer, apart
from the greater uncertainty of estimates due to the smaller
number of cases, the results were similar to those for advanced
disease (Figure 3). The fatality rate among those men who hardly
ever walked or biked increased by about two-fold (rate ratio was
1.85; 95% CI¼0.89–3.86) compared with men in the highest
average lifetime walking or bicycling of 120min per day, although
this increased rate was not significant.
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Figure 1 Multivariate rate ratio for lifetime average total physical activity
(average of age 30 and 50 years, and baseline age) as predictor of total
incidence of prostate cancer rates. Data were fitted using a Cox regression
model with restricted cubic splines. Data were adjusted for baseline age,
waist–hip ratio, height, diabetes, alcohol consumption, smoking status,
years of education, total energy intake, consumption of dairy product and
red meat and parental history with respect to prostate cancer. Dotted lines
represent 95% confidence limits.
Table 3 Age-adjusted and multivariate rate ratios for total, localised, advanced and fatal prostate cancer according to lifetime (age 30 and 50 years and
current age) work or occupational activity levels
Lifetime average work or occupational activity levels
Mostly sitting Sitting half of the time Mostly standing Heavy manual labour P-trend
Total-incidence prostate cancer
No. of cases 291 405 1141 111
Age-adjusted RR (95% CI) 1 0.81 (0.69–0.94) 0.80 (0.70–0.91) 0.72 (0.58–0.89) 0.003
Multivariate RR (95% CI)
a 1 0.80 (0.69–0.93) 0.79 (0.69–0.91) 0.72 (0.57–0.90) 0.007
Localised
No. of cases 123 184 439 36
Age-adjusted RR (95% CI) 1 0.86 (0.68–1.08) 0.71 (0.58–0.87) 0.55 (0.38–0.79) o0.001
Multivariate RR (95% CI)
a 1 0.87 (0.69–1.09) 0.72 (0.58–0.90) 0.55 (0.38–0.82) o0.001
Advanced
No. of cases 96 129 422 39
Age-adjusted RR (95% CI) 1 0.75 (0.57–0.97) 0.85 (0.68–1.07) 0.75 (0.52–1.10) 0.546
Multivariate RR (95% CI)
a 1 0.74 (0.56–0.97) 0.88 (0.69–1.12) 0.79 (0.54–1.18) 0.853
Fatal prostate cancer
No. of cases 16 21 82 8
Age-adjusted RR (95% CI) 1 0.65 (0.34–1.25) 0.86 (0.50–1.48) 0.84 (0.36–1.97) 0.814
Multivariate RR (95% CI)
a 1 0.64 (0.33–1.23) 0.88 (0.49–1.58) 0.89 (0.36–2.17) 0.679
Abbreviations: CI, confidence interval; RR, rate ratio.
aMultivariate RRs were adjusted for lifetime average walking or bicycling levels (hardly ever, o20, 20–40, 41–60 and
460min per day), age (years, continuous), waist–hip ratio (quartiles), height (continuous), diabetes (yes or no), alcohol consumption (current drinker, former drinker and never
drinker), smoking status (current smoker, former smoker and never smoked), years of education (1–9 years, 9–12 years, more than 12 years), total energy intake (calories,
continuous), consumption of dairy product (times per day, continuous) and red meat (times per day, continuous) and parental history with respect to prostate cancer (yes, no or
not known). A complete-subjects analysis automatically discarded missing values on any covariate.
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In this large population-based prospective cohort study of middle-
aged and elderly men, we observed a significant inverse dose–
response association between adult lifetime total PA and occupa-
tional and leisure-time walking or bicycling with prostate cancer
incidence. Compared with those who mostly sit during their main
work or occupation, men who sit half of the time or even less
experienced a 20% lower risk of prostate cancer. Compared with
men who walked or biked an average of 30min per day, every
increment of 30min per day was associated with an incidence
reduction of 7% for total, 8% for localised and 12% for advanced
disease. No significant changes in incidence were observed below
the lifetime walking or bicycling average duration of 30min per
day. Fatal prostate cancer rate was about two-fold higher among
men who hardly ever walked or biked compared with those men
who maintained the highest lifetime average of 120min per day,
although this increase was not statistically significant.
Our finding that the highest level of lifetime walking or
bicycling, averaged approximately more than 40 years before
diagnosis, was associated with 16% reduced risk is consistent with
a previous Canadian case–control study that reported a non-
significant 20% reduced risk of all prostate cancer for the top
lifetime recreational level (Friedenreich et al, 2004). Our finding of
an inverse association between lifetime walking or bicycling for 1h
per day or more and prostate cancer incidence supports the PA
recommendation of the World Cancer Research Fund/American
Institute for Cancer Research, which calls for a moderate activity of
longer duration, namely, 60min per day or more (WCRF/AICR,
2007). Furthermore, our finding of a strong inverse association
(26% risk reduction) between lifetime walking or bicycling for an
average of more than 1h per day and advanced prostate cancer
supports the findings of a previous large prospective cohort study
of American men (Patel et al, 2005). In the American Cancer
Society Cancer Prevention Study II Nutrition Cohort, baseline
recreational PA (recent-past only) corresponding to 35 MET-hours
per week or more (roughly corresponding to 1h of walking or
bicycling per day or more) was associated with a significant 31%
risk reduction for aggressive prostate cancer (Patel et al, 2005).
In the Health Professional follow-up study, a strong inverse
association (around 70% risk reduction) between recent-past
vigorous PA and metastatic prostate cancer was observed only in
men aged 65 years or older, with an evidence of effect modification
by age (Giovannucci et al, 2005). In our analysis, we found no
evidence of heterogeneity in the relationship across subgroups
defined by age, educational level and waist–hip ratio.
The biological mechanisms by which PA may decrease prostate
cancer risk are unknown, but PA may affect certain hormones
hypothesised to be associated with prostate carcinogenesis, including
insulin resistance (Goodyear and Kahn, 1998), adiponectin levels
(Kelesidis et al, 2006; Bluher et al, 2007), insulin-like growth
factors (Chan et al, 1998) and testosterone (Eaton et al, 1999).
Major strengths of our study include the large size of the cohort,
its population-based and prospective design, the relatively large
number of incident prostate cancers and the completeness of case
ascertainment through the Regional and National Cancer Register.
These features of the study substantially reduce the potential risk
of recall and selection biases, and, importantly, increase the
generalisability of the study findings. According to the National
Prostate Cancer Register data, the most common cause of dia-
gnosis in Sweden was clinical symptom (about 80% in our data),
followed by health checkup (Adolfsson et al, 2007). Prostate-speci-
fic antigen testing may be considered to introduce bias, as this
screening technique may only detect certain types of tumour.
There is no official recommendation in Sweden on PSA testing as
part of health checkups or for screening purposes in men without
lower urinary tract symptoms (Adolfsson et al, 2007), hence any bias
that may be introduced by PSA is of limited relevance in our data.
A potential limitation of this study is that PA was assessed
through a self-administered questionnaire, which could lead to
classification errors. Although our earlier validation study had
indicated an overall good validity and reproducibility, there were
Table 4 Age-adjusted and multivariate rate ratios for total, localised, advanced and fatal prostate cancer according to lifetime (age 30 and 50 years, and
current age) walking or bicycling levels
Lifetime average walking or bicycling, min per day
Hardly ever o20 20–40 41–60 460 P-trend
Total-incidence prostate cancer
No. of cases 55 391 706 411 403
Age-adjusted RR (95% CI) 0.99 (0.75–1.30) 0.97 (0.86–1.10) 1 0.96 (0.85–1.09) 0.87 (0.77–0.98) 0.049
Multivariate RR (95% CI)
a 1.03 (0.78–1.36) 0.97 (0.86–1.10) 1 0.96 (0.85–1.08) 0.86 (0.76–0.98) 0.028
Localised
No. of cases 21 142 293 179 161
Age-adjusted RR (95% CI) 0.92 (0.59–1.43) 0.86 (0.70–1.05) 1 1.01 (0.84–1.22) 0.84 (0.69–1.02) 0.447
Multivariate RR (95% CI)
a 0.98 (0.63–1.53) 0.86 (0.70–1.05) 1 1.00 (0.83–1.21) 0.84 (0.69–1.02) 0.393
Advanced
No. of cases 15 149 248 148 128
Age-adjusted RR (95% CI) 0.85 (0.50–1.44) 1.09 (0.89–1.34) 1 0.94 (0.77–1.16) 0.74 (0.60–0.92) 0.002
Multivariate RR (95% CI)
a 0.88 (0.52–1.49) 1.10 (0.89–1.35) 1 0.94 (0.76–1.15) 0.74 (0.59–0.92) 0.001
Fatal prostate cancer
No. of cases 4 26 44 28 25
Age-adjusted RR (95% CI) 1.71 (0.61–4.81) 1.19 (0.73–1.93) 1 0.93 (0.58–1.49) 0.73 (0.45–1.20) 0.062
Multivariate RR (95% CI)
a 1.81 (0.64–5.12) 1.21 (0.74–1.97) 1 0.90 (0.56–1.46) 0.72 (0.44–1.18) 0.044
Abbreviations: CI, confidence interval; RR, rate ratio.
aMultivariate RRs were adjusted for lifetime work or occupational activity levels (mostly sitting, sitting half of the time, mostly
standing and heavy manual labour), age (years, continuous), waist–hip ratio (quartiles), height (continuous), diabetes (yes or no), alcohol consumption (current drinker, former
drinker and never drinker), smoking status (current smoker, former smoker and never smoked), years of education (1–9 years, 9–12 years, more than 12 years), total energy
intake (calories, continuous), consumption of dairy product (times per day, continuous) and red meat (times per day, continuous) and parental history with respect to prostate
cancer (yes, no or not known). A complete-subjects analysis automatically discarded missing values on any covariate.
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individual characteristics such as body mass index (Norman et al,
2001). We found that the reliability of the historical PA
questionnaire was relatively high (Spearman–Brown reliability
were 0.7 at both age 50 and 30 years) (Orsini et al, 2007). Validity
measures of recalled PA in the distant past were not available.
However, a study on the quality of recall of PA in the distant past
(32–35 years) found that about 70% of the participants (mean age
58 vs 60 years in our study) were good recallers, and quality was
not significantly associated with age or body weight (Falkner et al,
2001).
As information on exposures was collected prospectively, any
non-differential misclassification would probably have attenuated
rather than exaggerated any true relationships, it is unlikely to
explain the significant associations observed. Our study was
observational, hence we cannot entirely rule out the possibility of
residual confounding. Nevertheless, age-adjusted and multivariate-
adjusted analyses provided overall similar results, suggesting that
this is unlikely to explain our findings.
The inverse relation with PA might be the result of reverse
causation if low PA was a result of an undiagnosed prostate cancer.
If this were true, we might expect the effect of PA on prostate
cancer risk to change after excluding the first 4 years of follow-up,
but it did not.
Missing data related to prostate cancer or both PA and prostate
cancer may lead to biased estimates (Demissie et al, 2003).
However, we observed only relatively small differences when
comparing complete-subject and multiple imputation approaches,
suggesting that the subsample with complete data was a random
subset of the entire sample.
Findings from this population-based prospective cohort study
show that not sitting for most of the time during work or occu-
pational activity and longer daily durations of the main component
of active living (walking or bicycling) may be associated with
reduced prostate cancer incidence. Our findings, which may have
major public health implications in the prevention of prostate
cancer, require confirmation by other well-designed studies.
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Figure 2 Multivariate rate ratio for lifetime average walking or bicycling
duration (average of age 30 and 50 years, and baseline age) as predictor of
total (A) and advanced (B) prostate cancer rates. Data were fitted using a
Cox regression model with restricted cubic splines (reference value at
30min per day). Data were adjusted for baseline age, lifetime work or
occupational activity, waist–hip ratio, height, diabetes, alcohol consump-
tion, smoking status, years of education, total energy intake, consumption of
dairy product and red meat and parental history with respect to prostate
cancer. Dotted lines represent 95% confidence limits.
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Figure 3 Multivariate rate ratios for lifetime average walking or bicycling
duration (average of age 30 and 50 years, and baseline age) as predictor of
fatal prostate cancer. Data were fitted using a Cox regression model with
restricted cubic splines (reference value at 30min per day). Data were
adjusted for baseline age, lifetime work or occupational activity, waist–hip
ratio, height, diabetes, alcohol consumption, smoking status, years of
education, total energy intake, consumption of dairy product and red meat
and parental history with respect to prostate cancer. Dotted lines represent
95% confidence limits.
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